Is Found a Good Fit for Maintenance? Plans and Costs Examined

Last reviewed: September 4, 2026 Last updated: September 4, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

Found can be an excellent maintenance fit if you have qualifying insurance or want a 12-month prepaid plan with bundled app-based support. Found's insurance track runs $99–$199/month with variable copays, and its longest cash-pay commitment—12 months prepaid—costs $2,028 total for semaglutide or $2,868 for tirzepatide. Month-to-month Found bills every four weeks (13 charges per year), averaging $313/month for semaglutide or $389/month for tirzepatide when normalized to calendar months.

PlexusDx serves cash-pay maintenance at lower rates across matching terms: $189/month for semaglutide or $289/month for tirzepatide on a month-to-month basis, billed by calendar month (12 charges per year). PlexusDx's six-month rate—its longest commitment—brings semaglutide to $149/month or tirzepatide to $249/month. PlexusDx also offers oral and microdose formats Found does not carry. The choice hinges on whether you use insurance, how long you want to commit, and whether you value Found's 24/7 AI companion and care-team app or prefer bare-bones cash pricing.

At-a-glance comparison

All pricing verified July 20, 2026 (Found cash) and Sept 4, 2026 (Found insurance track). PlexusDx pricing verified July 20, 2026.

Normalized 12-month cost comparison

Maintenance usually spans many months, so annual cost matters more than sticker price. Found bills every four weeks, creating 13 charges per calendar year; PlexusDx bills by calendar month (12 charges). We normalize both to 12-month totals using standard ongoing rates and prepaid totals only, verified at the dates shown.

Semaglutide injectable – 12-month cost

Tirzepatide injectable – 12-month cost

Key takeaway: PlexusDx delivers lower cash-pay annual costs across every matching term length. Found's 12-month prepaid plan sits between PlexusDx's three-month and six-month rates, offering a middle ground for those who want a longer commitment than six months but are paying cash.

Decision factors: strengths and gaps

Found's maintenance strengths

• Insurance track: If your plan covers Found's network clinicians (they are in-network for roughly one in three Americans), the $99–$199/month base may beat any cash program—though copays for visits and medication can add unpredictable costs.
• 12-month prepaid option: The longest commitment window among major telehealth GLP-1 providers, ideal for maintenance patients who want stable supply and are certain they will continue treatment.
• Bundled support: The Found app, 24/7 AI health companion (Aimee), licensed care team, and member community are included at every plan level—valuable if you want structured habit coaching and real-time question-answering during long-term treatment.
• Flexible cancellation: Cancel anytime in the app; full refund if you are not clinically eligible.
• HSA/FSA eligible: You can pay with tax-advantaged funds.

Found's maintenance gaps

• Higher cash rates: Across all like-for-like comparisons (month-to-month, three-month, six-month), Found's cash prices exceed PlexusDx by $100–$769 per year for semaglutide and $240–$1,199 per year for tirzepatide.
• Four-week billing: Thirteen charges per year instead of twelve creates a higher annual total and can complicate budgeting if you think in calendar months.
• Injectable only (compounded): Found does not offer oral or microdose GLP-1 formats. If you want to avoid injections or step down to a microdose for maintenance, you must look elsewhere or switch to Found's branded medication options (which carry separate pricing).
• Insurance variability: The $99–$199 insurance range is broad, and visit copays are not included in that figure; final cost depends on your specific plan and state.

PlexusDx's maintenance strengths

• Lower cash rates: Month-to-month semaglutide costs $100 less per month ($1,200/year savings) than Found's month-to-month rate; tirzepatide saves $70/month ($840/year). Six-month rates widen the gap further.
• Calendar-month billing: Twelve charges per year aligns with typical budgets and simplifies annual cost tracking.
• Format variety: Injectable, oral capsules, and microdose injection give you options to tailor delivery method and dosing strategy as maintenance needs evolve.
• Same price at every dose: No surprise cost increases if your provider adjusts your maintenance dose upward.
• Optional genetics add-on: $99 for current members; the genetic test does not select your medication (your provider decides) but can inform metabolism and side-effect risk discussions.

PlexusDx's maintenance gaps

• No insurance billing: If you have strong GLP-1 coverage, you cannot use it here.
• No 12-month plan: Six months is the longest commitment; patients seeking a full-year lock-in must renew mid-year.
• Minimal behavioral support: No app, no AI companion, no structured habit curriculum—just optional pharmacist check-ins. Maintenance patients who rely on daily accountability tools will need to source those separately.

Choose Found if…

• You have qualifying insurance and Found is in-network for your plan. The $99–$199/month base plus copays may undercut any cash alternative, especially for higher-dose tirzepatide.
• You want to commit for 12 months and pay upfront. The $2,028 semaglutide or $2,868 tirzepatide prepaid total buys price certainty and eliminates the risk of mid-year rate changes.
• You value integrated behavioral support. The app, 24/7 AI companion, care team, and community are built into every plan and can help sustain the habit changes that protect weight maintenance.
• You prefer a single bundled service. Found combines medication, prescribing, and coaching under one monthly charge with no separate add-ons to track.

Choose PlexusDx if…

• You are paying cash and want the lowest per-month rate. PlexusDx undercuts Found by $100/month on semaglutide and $70/month on tirzepatide at the month-to-month level; the six-month rate widens that gap to $70 and $40 per month respectively, compounding to four-figure annual savings.
• You want oral or microdose formats. Found offers injectable compounded GLP-1 only; PlexusDx gives you capsules or a microdose injection option for needle-free or lower-intensity maintenance.
• You prefer calendar-month billing. Twelve charges per year instead of thirteen simplifies budgeting and aligns with rent, utilities, and other monthly expenses.
• You do not need app-based coaching. If you have established maintenance habits and want only medication and prescriber access, PlexusDx's leaner model costs less and skips features you will not use.
• You want optional genetic data. The genetics add-on ($99 for members) can inform—but does not dictate—your provider's medication and dosing decisions during long-term treatment.

Where PlexusDx fits in your maintenance plan

PlexusDx serves cash-pay maintenance patients who have clear weight goals, stable habits, and a preference for transparent per-month pricing over bundled support services. The program works well if you have completed initial titration elsewhere (or with PlexusDx) and now need reliable, low-cost medication supply without behavioral coaching overhead. The six-month commitment option—$149/month for semaglutide, $249/month for tirzepatide—delivers meaningful savings over Found's comparable six-month rate ($219 and $289 respectively) while keeping you flexible enough to reassess twice per year.

If you later want to step down intensity, PlexusDx's microdose GLP-1 injection ($129/month, month-to-month only) or oral formats let you taper without switching providers. Found does not offer these options in its compounded line, so transitioning to a lower-maintenance phase would require moving to a branded medication (separate pricing) or leaving the platform. For patients who value format flexibility and cost control over app-based accountability, PlexusDx's maintenance model is purpose-built.

Methodology and freshness

We captured Found's cash-pay pricing by visiting its checkout flow on July 20, 2026, and verified the insurance track and prepaid structure on its first-party pricing page on September 4, 2026. PlexusDx pricing was verified at checkout on July 20, 2026. All figures reflect standard ongoing rates and prepaid totals only; no time-limited offers appear in this comparison.

The 12-month cost calculations are ours: we multiplied Found's per-charge price by 13 (its four-week billing creates 13 charges per calendar year) and PlexusDx's monthly rate by 12 (calendar-month billing). Prepaid totals—Found's 12-month plans—are published figures, not our calculations. We labeled every derived number accordingly.

Insurance pricing for Found ($99–$199/month) is a published range; actual cost depends on your plan, state, and copay structure. We did not model insurance scenarios because they vary by individual. If you have coverage, confirm final cost at Found's intake before comparing.

Frequently Asked Questions

Does Found's 12-month plan lock me in, or can I cancel early?

Found states you can cancel anytime in its app and offers a full refund if you are not clinically eligible. The 12-month prepaid plan is billed every 48 weeks, so you pay upfront; if you cancel mid-term, confirm refund terms for the unused portion directly with Found before committing.

Why does Found charge 13 times per year instead of 12?

Found bills every four weeks rather than by calendar month. Four weeks times 13 equals 364 days, close to a full year. This creates one extra charge compared to programs that bill on the first of each month, raising your annual total by roughly one month's cost.

Can I use my FSA or HSA card with PlexusDx?

PlexusDx accepts FSA and HSA cards like any payment method. Found explicitly labels its plans HSA/FSA eligible; PlexusDx does not highlight this on its site, but GLP-1 prescriptions for weight management generally qualify—confirm with your FSA/HSA administrator if unsure.

What happens if I need to change my dose during maintenance?

PlexusDx charges the same price at every dose, so a provider-directed increase or decrease costs the same monthly amount. Found's pricing is also dose-agnostic within each medication; you pay the plan rate regardless of whether you are on 0.5 mg or 2.4 mg semaglutide, for example.

Does Found's app and coaching justify the higher cash price?

That depends on whether you use it. If you log meals, interact with the AI companion daily, attend community events, and message the care team regularly, the $100–$120/month premium over PlexusDx's semaglutide rate may deliver value. If you ignore the app and want only medication, you are paying for features you do not use; PlexusDx's leaner model will cost less.

Sources

• Found pricing verified at checkout, July 20, 2026 (Source 1: PlexusDx editorial comparison)
• Found first-party pricing page, accessed September 4, 2026 (Source 2)
• PlexusDx pricing verified at checkout, July 20, 2026 (Source 1)
• PlexusDx program details, July 20, 2026 (Source 3: PlexusDx editorial notes)

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.